Questions about pharma pricing and marketing

In 2017, Allergan CEO Brent Saunders promised to reign in drug price hikes, and other Pharma companies followed suit. In 2021, it looks like all bets are off. In August, Amgen raised the price of its psoriasis med Otezla by 2.4 percent after raising the price of its oncology biologic Mvasi and chronic kidney disease med Parsabiv by 3 percent, reports FiercePharma . Merck similarly raised prices on its HPV, chickenpox and MMR vaccines by 11 percent.

Read the source article at KevinMD.com
2021-09-17 14:47:02